2.1. Percentage of Myeloid (BDCA-1+CD19−) and Plasmacytoid (BDCA-2+CD123+) Dendritic Cells in Peripheral Blood, Peritoneal Fluid, and Tumor Tissue from OC Patients. Here, CD19 is linked to neoplasm.